Search research articles
Contact Us
Filters
Showing results (151-160 of 228) with videos related to
Page
of 23
Sort By:
ESMO Open
|
May 30, 2020
<i>LKB1</i> mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial
Claudio Vernieri, Monica Ganzinelli, Eliana Rulli, et al.
Oncotarget
|
September 24, 2015
The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib
Luca Faloppi, Maristella Bianconi, Riccardo Giampieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2008
Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials
Emmanuel Mitry, Anthony L A Fields, Harry Bleiberg, et al.
Critical Reviews in Oncology/Hematology
|
December 18, 2025
Correlation of ORR and PFS with OS outcomes in phase III trials of immunotherapy in advanced NSCLC: Systematic review and meta-analysis
Fabio Salomone, Massimo Di Maio, Angela Viggiano, et al.
The Lancet. Oncology
|
July 26, 2013
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial
Marina Chiara Garassino, Olga Martelli, Massimo Broggini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2010
Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer
Daniel J Sargent, Silvia Marsoni, Genevieve Monges, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 31, 2002
Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy--a multicenter randomized trial
Patrizia Olmi, Sergio Crispino, Carlo Fallai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 29, 2008
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group
Jean-Pierre Pignon, Hélène Tribodet, Giorgio V Scagliotti, et al.
Health Services Insights
|
April 20, 2023
Centre for Statistical and Methodological Excellence (CESAME): A Consortium Initiative for Improving Methodology in Randomised Clinical Trials
Caroline Kamp Jørgensen, Markus Harboe Olsen, Niklas Nielsen, et al.
British Journal of Cancer
|
July 31, 2018
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma
Angiolo Gadducci, Federica Grosso, Giovanni Scambia, et al.
Page
of 23
Search research articles
Search
Showing results (151-160 of 228) with videos related to
Sort By:
Page
of 23
ESMO Open
|
May 30, 2020
<i>LKB1</i> mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial
Claudio Vernieri, Monica Ganzinelli, Eliana Rulli, et al.
Oncotarget
|
September 24, 2015
The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib
Luca Faloppi, Maristella Bianconi, Riccardo Giampieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2008
Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials
Emmanuel Mitry, Anthony L A Fields, Harry Bleiberg, et al.
Critical Reviews in Oncology/Hematology
|
December 18, 2025
Correlation of ORR and PFS with OS outcomes in phase III trials of immunotherapy in advanced NSCLC: Systematic review and meta-analysis
Fabio Salomone, Massimo Di Maio, Angela Viggiano, et al.
The Lancet. Oncology
|
July 26, 2013
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial
Marina Chiara Garassino, Olga Martelli, Massimo Broggini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2010
Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer
Daniel J Sargent, Silvia Marsoni, Genevieve Monges, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 31, 2002
Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy--a multicenter randomized trial
Patrizia Olmi, Sergio Crispino, Carlo Fallai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 29, 2008
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group
Jean-Pierre Pignon, Hélène Tribodet, Giorgio V Scagliotti, et al.
Health Services Insights
|
April 20, 2023
Centre for Statistical and Methodological Excellence (CESAME): A Consortium Initiative for Improving Methodology in Randomised Clinical Trials
Caroline Kamp Jørgensen, Markus Harboe Olsen, Niklas Nielsen, et al.
British Journal of Cancer
|
July 31, 2018
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma
Angiolo Gadducci, Federica Grosso, Giovanni Scambia, et al.
Page
of 23